Status:

UNKNOWN

Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee

Lead Sponsor:

Fidia Farmaceutici s.p.a.

Conditions:

Knee Osteoarthritis

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether intra-articular hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.

Eligibility Criteria

Inclusion

  • Symptomatic osteoarthritis of the knee.

Exclusion

  • No disorders which could interfere with study required assessments.

Key Trial Info

Start Date :

June 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2016

Estimated Enrollment :

332 Patients enrolled

Trial Details

Trial ID

NCT02187549

Start Date

June 1 2014

End Date

March 1 2016

Last Update

October 5 2015

Active Locations (21)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (21 locations)

1

Achieve Clinical Research

Birmingham, Alabama, United States, 35216

2

Alabama Clinical Therapeutics

Brimingham, Alabama, United States, 35235

3

Elite Clinical Studies

Phoenix, Arizona, United States, 85018

4

Arizona Research Center

Phoenix, Arizona, United States, 85023